Letter: Transient manifestations of immunological diseases in the child

Evaluation of the effects of AZD3480 on cardiac repolarization: a thorough QT/QTc study using moxifloxacin as a positive control.

Clinical pharmacology and therapeutics·2010

Disposition of debrisoquine and nortriptyline in Korean subjects in relation to CYP2D6 genotypes, and comparison with Caucasians.

British journal of clinical pharmacology·2003

Workplace drug testing (WDT) likely to increase in Europe. Report from the First European Symposium on WDT including selected abstracts.

European journal of clinical pharmacology·2000

Inhibition of debrisoquine hydroxylation with quinidine in subjects with three or more functional CYP2D6 genes.

British journal of clinical pharmacology·2000

Disposition of debrisoquine in Caucasians with different CYP2D6-genotypes including those with multiple genes.

Pharmacogenetics·2000

Lack of polymorphism of the conversion of losartan to its active metabolite E-3174 in extensive and poor metabolizers of debrisoquine (cytochrome P450 2D6) and mephenytoin (cytochrome P450 2C19).

European journal of clinical pharmacology·1999

Understanding peripheral arterial disease in the current era.

Lancet (London, England)·2026

Current advancements in the care of peripheral arterial disease: modern approaches to medical, endovascular, and surgical treatment.

Lancet (London, England)·2026

Peripheral arterial disease: adverse impacts, disparities in outcomes, and the path ahead.

Lancet (London, England)·2026

Developing roadmaps for advancing practice, research, and policy in the arts and health.

Lancet (London, England)·2026

Precision prevention and early detection: framework for a new clinical cancer control pathway.

Lancet (London, England)·2026

Switch to injectable cabotegravir-rilpivirine given every 8 weeks in adolescents living with HIV with virological suppression in sub-Saharan Africa (LATA): a randomised, open-label, multicentre, 96-week non-inferiority trial.

Lancet (London, England)·2026

Reciprocal mediation of immuno-inflammation and insulin resistance in the risk of chronic kidney disease among patients with coronary artery disease: insights from neutrophil-to-lymphocyte ratio and triglyceride-glucose index.

Frontiers in immunology·2026

Defining the Genetic and Phenotypic Landscape of Primary Immune Regulatory Disorders Using the ClinGen Validation Framework.

medRxiv : the preprint server for health sciences·2026

Association of IFN-γ +874 T/A Polymorphism With COVID-19 Susceptibility, Severity, and Inflammatory Response: A Case-Control Study From Southern Iran.

Journal of clinical laboratory analysis·2026

Cardiac tamponade caused by effusive-constrictive pericarditis in a patient with common variable immunodeficiency: a case report.

International journal of emergency medicine·2026

CONFIRMATORY VALIDATION AND CLUSTER CLASSIFICATION OF THE IRRITABLE BOWEL SYNDROME SYMPTOM SEVERITY SCALE (IBS-SSS).

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

Comparative serious infection and sepsis risks with advanced therapies in IMIDs: a Bayesian network meta-analysis.

The Journal of infection·2026

Related Experiment Videos

Letter: Transient manifestations of immunological diseases in the child

Related Concept Videos

Evaluation of the effects of AZD3480 on cardiac repolarization: a thorough QT/QTc study using moxifloxacin as a positive control.

Disposition of debrisoquine and nortriptyline in Korean subjects in relation to CYP2D6 genotypes, and comparison with Caucasians.

Workplace drug testing (WDT) likely to increase in Europe. Report from the First European Symposium on WDT including selected abstracts.

Inhibition of debrisoquine hydroxylation with quinidine in subjects with three or more functional CYP2D6 genes.

Disposition of debrisoquine in Caucasians with different CYP2D6-genotypes including those with multiple genes.

Lack of polymorphism of the conversion of losartan to its active metabolite E-3174 in extensive and poor metabolizers of debrisoquine (cytochrome P450 2D6) and mephenytoin (cytochrome P450 2C19).

Understanding peripheral arterial disease in the current era.

Current advancements in the care of peripheral arterial disease: modern approaches to medical, endovascular, and surgical treatment.

Peripheral arterial disease: adverse impacts, disparities in outcomes, and the path ahead.

Developing roadmaps for advancing practice, research, and policy in the arts and health.

Precision prevention and early detection: framework for a new clinical cancer control pathway.

Switch to injectable cabotegravir-rilpivirine given every 8 weeks in adolescents living with HIV with virological suppression in sub-Saharan Africa (LATA): a randomised, open-label, multicentre, 96-week non-inferiority trial.

Reciprocal mediation of immuno-inflammation and insulin resistance in the risk of chronic kidney disease among patients with coronary artery disease: insights from neutrophil-to-lymphocyte ratio and triglyceride-glucose index.

Defining the Genetic and Phenotypic Landscape of Primary Immune Regulatory Disorders Using the ClinGen Validation Framework.

Association of IFN-γ +874 T/A Polymorphism With COVID-19 Susceptibility, Severity, and Inflammatory Response: A Case-Control Study From Southern Iran.

Cardiac tamponade caused by effusive-constrictive pericarditis in a patient with common variable immunodeficiency: a case report.

CONFIRMATORY VALIDATION AND CLUSTER CLASSIFICATION OF THE IRRITABLE BOWEL SYNDROME SYMPTOM SEVERITY SCALE (IBS-SSS).

Comparative serious infection and sepsis risks with advanced therapies in IMIDs: a Bayesian network meta-analysis.

Related Experiment Videos

Letter: Transient manifestations of immunological diseases in the child

Related Concept Videos

Related Articles